Vitafoods Asia 2026

Vitafoods Asia 2026 brought together leading ingredient suppliers, nutraceutical brands, manufacturers, researchers and industry experts from across the Asia-Pacific region to explore the latest developments in nutraceuticals, functional ingredients, dietary supplements, nutrition science and health and wellness innovation.

Representing Vedic Lifesciences at Vitafoods Asia 2026 in Bangkok, Kriti Chaudhary, Associate Director - Partnerships & Strategy, engaged with global ingredient innovators, brands and industry professionals to discuss the growing importance of clinical evidence, scientific substantiation and evidence-based product development in the nutraceutical industry.

A recurring theme throughout the conversations was a fundamental question for ingredient and product innovators: Can the science behind your ingredient actually support the claim you want to make?

As the global nutraceutical market becomes increasingly competitive and regulatory expectations around health claims continue to evolve, having an impressive ingredient dossier is no longer enough. Brands need robust, relevant and scientifically credible human evidence that can withstand scientific scrutiny and support meaningful product claims.

At Vitafoods Asia 2026, discussions centred around the role of clinical research and strategic study design in building stronger evidence for nutraceutical ingredients and finished products. From selecting appropriate clinical endpoints and study populations to understanding claim requirements and regulatory expectations, the right clinical strategy can help companies make more informed decisions before investing in a clinical trial. The event also provided an opportunity to exchange perspectives on the evolving APAC nutraceutical market, emerging ingredient innovations, global market expansion and the increasing demand for evidence-backed health and wellness products.

For Vedic Lifesciences, Vitafoods Asia 2026 was an opportunity to strengthen relationships with existing partners, connect with new industry stakeholders and continue conversations around clinical trials, claim substantiation, regulatory science and evidence-based product development.

As the nutraceutical industry moves toward greater scientific accountability, the question is no longer simply whether an ingredient works. It is whether you have the right evidence to prove it and the right clinical strategy to make that evidence commercially meaningful.